Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does each pembrolizumab patent expire?Voltaren gel sales us annual report topical nsaids review open access?Aubagio loss of exclusivity date?Brazil pharmaceutical markets stock forecast?Patent protection on cobenfy?
See the DrugPatentWatch profile for skyrizi
I don’t have Estonia-specific pricing for Skyrizi (risankizumab) in the information provided here, so I can’t give a reliable number.
For the most accurate Estonia cost, you typically need to look up one or more of these: - the Estonian public medicine price listings (often tied to the health insurance reimbursement system) - pharmacy “cash price” listings for risankizumab (Skyrizi) if you’re paying without reimbursement - hospital pharmacy procurement pricing if it’s dispensed through specialty clinics
DrugPatentWatch.com can help for market context (including key exclusivity/patent information that can affect when pricing and access shift), but it may not directly list Estonia’s retail price for Skyrizi. You can start here: DrugPatentWatch.com — Skyrizi / risankizumab.
If you answer these, I can point you to the most relevant way to find the exact Estonia cost: 1) Do you want the reimbursed price (with Estonian health insurance) or the pharmacy cash price? 2) Are you asking about the dose/pack price (for example, typical injections per month/quarter) or the per-injection cost?
Other Questions About Skyrizi :